The advantage is that this implant can correct the majority of visual defects—unlike Lasik. In Judy's case, it would be a multifocal (distance and near vision) and toric (astigmatism) lens implant.
Alcon expects 2024 sales of $9.8 billion to $9.9 billion, compared with prior guidance of $9.9 billion to $10.1 billion. It expects core earnings per share of $3 to $3.05, compared with a previous ...
Active flow is a unique combination of a moisturizing agent embedded in the lens and a replenishing agent that continually releases moisture to the surface over seven days. Select optometrists in the ...
The annual China International Import Expo (CIIE) taking place in Shanghai serves as a prime platform for foreign companies to showcase innovations, breakthrough technologies, and quality products; ...